Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis

British Journal of Rheumatology

Volumn 36, Issue 4, 1997, Pages 491-493

  Tani, Yoshitaka ^a   Sato, Hiroshi ^a   Tanaka, Naruhiro ^a   Hukuda, Sinsuke ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Ankylosing spondylitis; Antibody; Bacteria; Lipopolysaccharide

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI;

EID: 0030845547     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.4.491     Document Type: Article

References (14)

1. Ebringer A, Ahmadi K, Fielder M et al. Molecular mimicry: The geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin Rheumatol 1996;15(suppl. 1):57-61.
2. Mäki-Ikola O, Lehtinen K, Nissilä M, Granfors K. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Br J Rheumatol 1994;33: 1025-9.
3. Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis. Ann Rheum Dis 1973;32:354-63.
4. Arnett FC, Edworthy S, Block DA et al. The 1987 revised ARA criteria for rheumatoid arthritis. Arthritis Rheum 1987; 30:S17.
5. Caffery MFP, James DCO. Human lymphocyte antigen association in ankylosing spondylitis. Nature 1973;242:121.
6. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen W27 with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
7. Schwimmbeck P, Yu DTY, Oldstone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-81.
8. Fielder M, Pirt SJ, Tarpey I et al. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett 1995;369:243-8.
9. Tani Y, Tiwana H, Hukuda S et al. Antibodies to Klebsiella, Proteus and HLA-B27 peptide in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1997; 24: 109-14.
10. Tani Y, Sato H, Nishioka J, Hukuda S. Autoantibodies to collagens in Japanese patients with ankylosing spondylitis. Clin Exp Rheumatol; in press.
11. Van Bohemen CG, Weterings E, Goeithe HS, Grumet FC, Zanen HC. Enterobacterial involvement in the pathogenesis of secondary ankylosing spondylitis. Br J Rheumatol 1988;27 (suppl. II):61-7.
12. Alvaro-Garcia JM, Ariza A, Cascon G, Sabando P, Ossorio C. Enterobacteria and ankylosing spondylitis. Scand J Rheumatol 1987;16:221-2.
13. Toivanen P, Koskimies S, Granfors K, Eerola E. Bacterial antibodies in HLA-B27+ healthy individuals. Arthritis Rheum 1993;36:1633-5.
14. Akaza T, Imanishi T, Fujiwara K et al. HLA alleles and haplotypes of Japanese population. MHC & IRS 1994; 1(suppl.):219-26.